| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |